Chrysin-loaded PCL nanocapsule spray as a topical strategy against cutaneous candidiasis
- 1Center for Studies in Biopharmacy (CEB), Department of Pharmacy, Postgraduate Program in Pharmaceutical Sciences, Federal University of Paraná - UFPR
- 2Metabolic Diseases Research Group (GPDM), Department of Clinical Analisys, Postgraduate Program in Pharmaceutical Sciences, Federal University of Paraná - UFPR
- 3Postgraduate Program in Pharmaceutical Sciences, State University of Midwest (UNICENTRO)
Abstract
Introduction: Candida albicans , the most prevalent fungal pathogen in humans, poses increasing therapeutic challenges due to rising resistance to conventional azole antifungals, driving interest in natural alternatives. Chrysin (5,7- dihydroxyflavone) is a flavonoid with promising biological activities that are limited by poor aqueous solubility and low bioavailability. This study aimed to develop and characterize chrysin-loaded poly (ε-caprolactone) (PCL) nanocapsules in a spray formulation for topical treatment of cutaneous candidiasis.
Methods: Nanocapsules were produced by interfacial deposition of the preformed polymer and characterized for particle size, zeta potential, encapsulation efficiency, and morphology. Their performance was further evaluated through in vitro release studies, antifungal activity against C. albicans, antioxidant activity, and spray performance.
Results and Discussion: The formulation exhibited nanometric size (207.6 ± 4.63 nm), low polydispersity (0.174 ± 0.04), high encapsulation efficiency (87.28% ± 0.77%), and sustained drug release over 120 h, with antifungal activity substantially superior to free chrysin, requiring 5- to 8-fold lower concentrations to achieve equivalent inhibitory and fungicidal effects, and enhanced antioxidant efficacy at lower concentrations. The spray device delivered consistent and reproducible doses (118.5% of theoretical content, RSD 5.78%). These findings demonstrate that chrysin-loaded PCL nanocapsules successfully overcome solubility limitations, enhance antifungal and antioxidant activities, and provide sustained release, representing a promising nanotechnology-based alternative for cutaneous candidiasis treatment with convenient topical application.
Related
- Enhanced Cutaneous Delivery of Quercetin Using Poloxamer 407–Cellulose Derivative Systems: A Topical Approach Aimed at Melanoma Therapy
- Topical Cotton Boll Extract as an Adjunct to Standard Pentavalent Antimonial Therapy in Cutaneous Leishmaniasis Caused by Leishmania tropica: A Randomized Pilot Clinical Trial.
- Ocular tissue distribution of Ocular Surface Immune Globulins Following Topical and Subconjunctival Administration: A Novel Strategy for Mitigation of ADC-Associated Ocular Toxicity
- Comparing the Cutaneous Impacts of a Topical Restructuring Serum versus. Injected Hyaluronic Acid (HA) and Their Combination as Potential Anti-Aging Strategies in Chinese Women: An In Vivo Study
- Feline-Derived Lactiplantibacillus plantarum-Aloe Vera Polysaccharide Hydrogel as a Topical Control Strategy for Staphylococcus pseudintermedius-Infected Wounds.
BibTeX
@article{silva2026chrysinloaded,
title = {{Chrysin-loaded PCL nanocapsule spray as a topical strategy against cutaneous candidiasis}},
author = {Milena Luiza da Silva and Eric Luiz Domingos and Ahmad Kassem El Zein and Roberto Pontarolo and Marcel Henrique Marcondes Sari and Jéssica Brandão Reolon and Luana Mota Ferreira},
journal = {Frontiers in Pharmacology},
year = {2026},
month = oct,
doi = {10.3389/fphar.2026.1975087},
url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1975087/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Chrysin-loaded PCL nanocapsule spray as a topical strategy against cutaneous candidiasis
AU - Milena Luiza da Silva
AU - Eric Luiz Domingos
AU - Ahmad Kassem El Zein
AU - Roberto Pontarolo
AU - Marcel Henrique Marcondes Sari
AU - Jéssica Brandão Reolon
AU - Luana Mota Ferreira
PY - 2026
DA - 2026/10/15
JO - Frontiers in Pharmacology
DO - 10.3389/fphar.2026.1975087
UR - https://www.frontiersin.org/articles/10.3389/fphar.2026.1975087/full
AB - Introduction: Candida albicans , the most prevalent fungal pathogen in humans, poses increasing therapeutic challenges due to rising resistance to conventional azole antifungals, driving interest in natural alternatives. Chrysin (5,7- dihydroxyflavone) is a flavonoid with promising biological activities that are limited by poor aqueous solubility and low bioavailability. This study aimed to develop and characterize chrysin-loaded poly (ε-caprolactone) (PCL) nanocapsules in a spray formulation for topical treatment of cutaneous candidiasis. Methods: Nanocapsules were produced by interfacial deposition of the preformed polymer and characterized for particle size, zeta potential, encapsulation efficiency, and morphology. Their performance was further evaluated through in vitro release studies, antifungal activity against C. albicans, antioxidant activity, and spray performance. Results and Discussion: The formulation exhibited nanometric size (207.6 ± 4.63 nm), low polydispersity (0.174 ± 0.04), high encapsulation efficiency (87.28% ± 0.77%), and sustained drug release over 120 h, with antifungal activity substantially superior to free chrysin, requiring 5- to 8-fold lower concentrations to achieve equivalent inhibitory and fungicidal effects, and enhanced antioxidant efficacy at lower concentrations. The spray device delivered consistent and reproducible doses (118.5% of theoretical content, RSD 5.78%). These findings demonstrate that chrysin-loaded PCL nanocapsules successfully overcome solubility limitations, enhance antifungal and antioxidant activities, and provide sustained release, representing a promising nanotechnology-based alternative for cutaneous candidiasis treatment with convenient topical application.
SN - 1663-9812
ER -